A new in-person event, celebrating extraordinary minds & ideas intersecting health & medicine.
LIFE ITSELF features extraordinary thinkers intersecting health &
medicine — from research, technology, government, entertainment &
New ideas unveiled — Challenging topics debated — Trailblazers celebrated
San Diego, California
Dr Sanjay Gupta is Founder and Co-Host of LIFE ITSELF.
Best known as the Chief Medical Correspondent for CNN, Sanjay is also an Associate Professor of Neurosurgery and practices at Emory University Hospital.
Sanjay has won multiple national Emmy, Peabody and DuPont Awards, some of the highest honors in broadcast television. For the last twenty years, he has covered the biggest medical and health stories in the world, and has hosted dozens of groundbreaking documentaries on topics such as concussions, medical marijuana, opioids and brain science. Gupta has also distinguished himself as a war zone and natural disaster reporter, having traveled to 153 countries, covering world events, such as the earthquake in Haiti, the tsunami in South Asia and Japan, the hurricanes in Puerto Rico, as well as the conflicts in Iraq, Afghanistan and the Middle East. On several occasions, Dr Gupta has performed surgical procedures in the field, including five emergent brain operations in the middle of a desert tent during the war in Iraq.
Since early 2020, he has led CNN's worldwide coverage on the Coronavirus Pandemic.
Sanjay is the host of the CNN Original Series, Chasing Life, which follows his world travels in search of living longer, healthier and happier. He is also the host, executive producer and writer of the HBO Original Documentary "One Nation Under Stress", which offered a revealing look at the declining life expectancy in the United States.
Gupta has been named one of People Magazine's "Sexiest Men Alive", a pop culture icon by USA Today and one of the "Ten Most Influential Celebrities" by Forbes Magazine. He has been awarded several awards for his humanitarian work.
As a practicing neurosurgeon, Gupta is a member of the American Board of Neurosurgery, the American Association of Neurosurgeons, and the Congress of Neurological Surgeons. In 2020, he was inducted into the National Academy of Medicine, considered one of the highest honors in the field.
He is the author of three New York Times best-selling books, Chasing Life, Cheating Death and Monday Mornings. His fourth book, Keep Sharp: Building a Better Brain will be published in 2021.
Marc Hodosh is Founder and Co-Host of LIFE ITSELF.
Previously, Marc co-created and hosted TEDMED, the health and medical version of the TED Conference. After selling TEDMED he continued to focus on the intersection of health innovations and media, with a particular focus on human aging and longevity.
Prior, Marc led the X PRIZE for Genomics, a $10 million competition to inspire rapid and cost effective genome sequencing technology, which followed the successful $10 million Ansari Space X PRIZE.
He has been a consultant to inventor Dean Kamen at DEKA Research & Development and also chaired Dean's FIRST Robotics competition within the Boston region — a non-profit foundation which inspires high school students to pursue careers in science and technology.
Additionally, Marc founded and sold ID One, specializing in facial recognition technology for the U.S. military and intelligence communities. Earlier he led business development at Viisage Technology, a biometric and secure ID company.
Marc became interested in health and medicine during high school and college, while volunteering as an EMT (Emergency Medical Technician) with the local ambulance services, as well as through his experiences working in a hospital emergency room. After a year at Boston University Medical School, he decided to pursue business and entrepreneurial endeavors by inventing and patenting consumer products, which were distributed through Bed Bath & Beyond, QVC television, Toys-R-Us, and others.
In September 2013, Arthur Levinson was named chief executive officer of Calico, a company focused on health, aging, and well-being.
Levinson joined Genentech in 1980 as a senior scientist, became head of R&D in 1993, and served as chief executive officer of Genentech from 1995 to 2009. Levinson serves as the chairman of the board of Apple, and previously served as a director of Google from 2004 to 2009.
Levinson has authored or co-authored more than 80 scientific articles and has been named an inventor on 11 United States patents. He was inducted into the Biotech Hall of Fame at the 2003 Biotech Meeting of chief executive officers. BusinessWeek named Levinson one of the "Best Managers of the Year" in 2004 and 2005, and Institutional Investor named him "America's Best CEO" in the biotech category four years in a row (2004–2007). In 2006, Princeton University awarded Levinson the James Madison Medal for a distinguished career in scientific research and in biotechnology. In 2008, Levinson was elected as a Fellow to the American Academy of Arts & Sciences. In 2011 Levinson received the American Association for Cancer Research Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, and in 2012 he received the Cold Spring Harbor Laboratory Double Helix Medal. In 2014 he received the Alumnus Summa Laude Dignatus Award from the University of Washington and was honored as a recipient of the National Medal of Technology and Innovation by President Obama. The Franklin Institute named Levinson as the recipient of the 2020 Bower Award for Business Leadership, which recognizes individuals who have demonstrated outstanding leadership in an American business or industry while adhering to the highest ethical standards.
Levinson received his Bachelor of Science degree from the University of Washington, earned a doctorate in biochemical sciences from Princeton University, and did his postdoctoral work with Mike Bishop and Harold Varmus at UCSF.
Dr. Fauci was appointed director of NIAID in 1984. He oversees an extensive portfolio of basic and applied research to prevent, diagnose, and treat established infectious diseases such as HIV/AIDS, respiratory infections, diarrheal diseases, tuberculosis and malaria as well as emerging diseases such as Ebola and Zika. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. The NIAID budget for fiscal year 2020 is an estimated $5.9 billion.
Dr. Fauci has advised six presidents on HIV/AIDS and many other domestic and global health issues. He was one of the principal architects of the President's Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
Dr. Fauci also is the longtime chief of the Laboratory of Immunoregulation. He has made many contributions to basic and clinical research on the pathogenesis and treatment of immune-mediated and infectious diseases. He helped pioneer the field of human immunoregulation by making important basic scientific observations that underpin the current understanding of the regulation of the human immune response. In addition, Dr. Fauci is widely recognized for delineating the precise ways that immunosuppressive agents modulate the human immune response. He developed effective therapies for formerly fatal inflammatory and immune-mediated diseases such as polyarteritis nodosa, granulomatosis with polyangiitis (formerly Wegener's granulomatosis), and lymphomatoid granulomatosis. A 1985 Stanford University Arthritis Center Survey of the American Rheumatism Association membership ranked Dr. Fauci's work on the treatment of polyarteritis nodosa and granulomatosis with polyangiitis among the most important advances in patient management in rheumatology over the previous 20 years.
Dr. Fauci has made seminal contributions to the understanding of how HIV destroys the body's defenses leading to its susceptibility to deadly infections. Further, he has been instrumental in developing treatments that enable people with HIV to live long and active lives. He continues to devote much of his research to the immunopathogenic mechanisms of HIV infection and the scope of the body's immune responses to HIV.
In a 2020 analysis of Google Scholar citations, Dr. Fauci ranked as the 41st most highly cited researcher of all time. According to the Web of Science, he ranked 8th out of more than 2.2 million authors in the field of immunology by total citation count between 1980 and January 2020.
Dr. Fauci has delivered major lectures all over the world and is the recipient of numerous prestigious awards, including the Presidential Medal of Freedom (the highest honor given to a civilian by the President of the United States), the National Medal of Science, the George M. Kober Medal of the Association of American Physicians, the Mary Woodard Lasker Award for Public Service, the Albany Medical Center Prize in Medicine and Biomedical Research, the Robert Koch Gold Medal, the Prince Mahidol Award, and the Canada Gairdner Global Health Award. He also has received 45 honorary doctoral degrees from universities in the United States and abroad.
Dr. Fauci is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society, as well as other professional societies including the American College of Physicians, the American Society for Clinical Investigation, the Association of American Physicians, the Infectious Diseases Society of America, the American Association of Immunologists, and the American Academy of Allergy, Asthma & Immunology. He serves on the editorial boards of many scientific journals; as an editor of Harrison's Principles of Internal Medicine; and as author, coauthor, or editor of more than 1,300 scientific publications, including several textbooks.
Patrice A. Harris, MD, MA, a psychiatrist from Atlanta, became the 174th president of the American Medical Association in June 2019, and the organization's first African-American woman to hold this position. Dr. Harris has diverse experience as a private practicing physician, public health administrator, patient advocate and medical society lobbyist.
Dr. Harris currently spearheads the AMA's efforts to end the opioid epidemic and has been chair of the AMA Opioid Task Force since its inception in 2014. During her presidency, Dr. Harris will continue to lead the task force as it works across every state to eliminate barriers to treatment, provide patients with access to affordable, non-opioid pain care, and fight the stigma faced by those with substance use-disorders.
Having served on the AMA Board of Trustees since 2011, and as chair from 2016 to 2017, she has long been a mentor, a role model and an advocate. Prior to serving on the board, Dr. Harris honed her broad knowledge and deep understanding of health care issues through various leadership roles. At the AMA these included having served for many years on the AMA Council on Legislation, including a term as chair, and on multiple AMA task forces on topics such as health information technology, payment and delivery reform, and private contracting. Beyond the AMA she has held positions of leadership with the American Psychiatric Association, the Georgia Psychiatric Physicians Association, the Medical Association of Georgia, and The Big Cities Health Coalition, where she chaired this forum composed of leaders from America's largest metropolitan health departments.
Growing up in Bluefield, West Virginia, Dr. Harris dreamt of entering medicine at a time when few women of color were encouraged to become physicians. Dr. Harris spent her formative years at West Virginia University, earning a BA in psychology, an MA in counseling psychology and, ultimately, a medical degree in 1992. It was during this time that her passion for helping children emerged, and she completed her psychiatry residency and fellowships in child and adolescent psychiatry and forensic psychiatry at the Emory University School of Medicine.
Two themes that govern Dr. Harris's professional life are a passion to improve the lives of children and service
to others. A recognized expert in children's mental health and childhood trauma, Dr. Harris has led efforts on both local and national levels to integrate public health, behavioral health and primary care services with supports for employment, housing and education.
A distinguished fellow of the American Psychiatric Association, Dr. Harris continues in private practice and currently consults with both public and private organizations on health service delivery and emerging trends in practice and health policy. She is an adjunct assistant professor in the Emory Department of Psychiatry and Behavioral Sciences, and an adjunct clinical assistant professor in psychiatry and behavioral sciences at Morehouse School of Medicine.
Dean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology's virtues and by so doing to change the culture of the United States.
As an inventor, he holds more than 1000 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as oncology, neonatology, and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. Then, working with leading diabetes researchers, Dean pioneered the design and adoption of the first portable insulin pump. It was quickly demonstrated that using a pump could much more effectively control patients' blood glucose levels. . At age 30, he sold AutoSyringe to Baxter Healthcare Corporation.
Following the sale of AutoSyringe, Inc., he founded DEKA Research & Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients. Kamen led DEKA's development of the HomeChoiceTM peritoneal dialysis system for Baxter International Inc. The HomeChoiceTM system allows patients to be dialyzed in the privacy and comfort of their home and quickly became the worldwide market leader. Kamen also led the development of technology to improve slide preparation for the CYTYC (now Hologic Inc.) ThinPrep® Pap Test. Kamen-led DEKA teams have also developed critical components of the UVARTM XTSTM System, an extracorporeal photophereisis device marketed by Therakos, a unit of Johnson & Johnson, for treatment of T-Cell lymphoma. An advanced prosthetic arm in development for DARPA should advance the quality of life for returning injured soldiers. Other notable developments include the HydroflexTM surgical irrigation pump for C.R. Bard, the CrownTM stent, an improvement to the original Palmaz-Schatz stent, for Johnson & Johnson, the iBOTTM mobility device, and the Segway® Human Transporter.
Kamen has received many awards for his efforts. Notably, Kamen was awarded the National Medal of Technology in 2000. Presented by President Clinton, this award was in recognition for inventions that have advanced medical care worldwide, and for innovative and imaginative leadership in awakening America to the excitement of science and technology. Kamen was elected a member of the National Academy of Engineering in 1997. He was awarded the Lemelson-MIT Prize in 2002, and was inducted into the National Inventors Hall of Fame in May 2005. He is a Fellow of the American Institute for Medical & Biological Engineering, as well as many other national and international engineering organizations.
In addition to DEKA, one of Dean's proudest accomplishments is founding both FIRST® (For Inspiration and Recognition of Science and Technology) and FIRST® Global, organizations dedicated to motivating the next generation to understand, use and enjoy science and technology.
Kimbal Musk is chef, restauranteur, and philanthropist. His personal mission is to pursue an America where everyone has access to real food. Mr. Musk has been named a Global Social Entrepreneur by the World Economic Forum. He is the Co-Founder and Executive Chairman of three businesses - The Kitchen Restaurant Group, Big Green, and Square Roots - with real food missions that are rapidly scaling across the United States.
The Kitchen Restaurant Group -- with its three concepts Next Door, Hedge Row, and The Kitchen -- serves real food at every price point and has created over a thousand mission driven jobs. The restaurants source sustainably grown food from American farmers, stimulating the local farm economy to the tune of millions of dollars a year. Mr. Musk's non-profit organization, Big Green, builds permanent, outdoor Learning Garden classrooms in hundreds of underserved schools across America reaching over 350,000 students everyday. His tech-enabled food company, Square Roots, builds urban farms in climate-controlled shipping containers with the mission to bring real food to people in cities around the world by empowering next-gen farmers.
Mr. Musk is on the board for Tesla and SpaceX. Follow him on Twitter @Kimbal and Instagram @KimbalMusk.
Brian Grazer is an Oscar-winning producer and New York Times bestselling author. His films and television shows have been nominated for forty-three Academy Awards and 195 Emmys. His work includes A Beautiful Mind, 24, Apollo 13, Splash, Arrested Development, Empire, 8 Mile, Friday Night Lights, American Gangster, Splash, Genius, among others. He is the author of the new release Face to Face: The Art of Human Connection and the New York Times bestseller A Curious Mind: The Secret to a Bigger Life. Grazer was named one of Time magazine's 100 Most Influential People in the World and is the cofounder of Imagine Entertainment along with his longtime partner, Ron Howard.
Nicole Shanahan is a California based attorney and the founder and president of Bia-Echo Foundation, a private foundation that aims to invest in changemakers at the forefront of innovation who are tackling some of the world's greatest challenges: reproductive longevity & equality, criminal justice reform and a healthy & livable planet. Initial investments and projects led by Bia-Echo include, the launch of the world's first Center for Reproductive Longevity and Equality at the Buck Institute for Research on Aging and the Stanford Computational Policy Lab to drive social impact on criminal justice reform via data analysis and technical innovation. Prior to launching Bia-Echo, Nicole supported these efforts through the Sergey Brin Family Foundation.
Nicole is also the founder and chair of the Board of ClearAccessIP, an integrated patent management company using AI to help the creators and owners of IP assets effectively develop, manage and transact patent-protected technology. Nicole is a research fellow at CodeX, the Stanford Center of Legal Informatics, a joint center between Stanford Law School and Computer Science, where she launched the Smart Prosecution project, a multi-disciplinary effort applying data science to the prosecutorial process, involving partnerships with district attorneys and community organizations. Apart from the practical applications of legal technology, her academic research centers on an extension of Ronald Coase's work on transaction cost theory. Entitled, "Coasean Mapping" she theorizes on the pace and nature of society's adoption of artificial intelligence for law and government.
Nicole is a graduate of Santa Clara University Law School and the University of Puget Sound. She currently resides in the San Francisco Bay Area with her family.
Dr. Larry Brilliant is a physician and epidemiologist, CEO of Pandefense Advisory, and Chair of the Advisory Board of the NGO Ending Pandemics. He is also a senior advisor to Jeff Skoll and serves on the board of the Skoll Foundation. Dr. Brilliant was previously the president and CEO of the Skoll Global Threats Fund, vice president of Google, and the founding executive director of Google.org. He also co-founded the Seva Foundation, an NGO whose programs have given back sight to more than 5 million blind people in two dozen countries. In addition, he co-founded The Well, a progenitor of today's social media platforms. Earlier in his career, Dr. Brilliant was an associate professor of epidemiology and international health planning at the University of Michigan. Dr. Brilliant lived in India for nearly a decade where he was a key member of the successful WHO Smallpox Eradication Programme for SE Asia as well as the WHO Polio Eradication Programme. More recently, he was chairman of the National Biosurveillance Advisory Committee, which was created by presidential directive of President George W. Bush, he was a member of the World Economic Forum's Agenda Council on Catastrophic Risk, and a "First Responder" for CDC's bio-terrorism response effort. Recent awards include the TED Prize, Time magazine's 100 Most Influential People, "International Public Health Hero" and four honorary doctorates. He has lectured at Oxford, Harvard, Berkeley and many other colleges, spoken at the Royal Society, the Pentagon, NIH, the United Nations, and some of the largest companies and nonprofits all over the world. He has written for Forbes, the Wall Street Journal, the Guardian, and other magazines and peer reviewed journals and was part of the Global Business Network where he learned scenario planning. Dr. Brilliant is the author of "Sometimes Brilliant" a memoir about working to eradicate smallpox, and a guide to managing vaccination programs entitled "The Management of Smallpox Eradication."
Norman Lear is a television and film writer/producer whose dynamic career in Hollywood has encompassed both the Golden Age and Streaming Era. At 98, Norman Lear has no plans to retire.
His production banner, ACT III, has a first look deal with Sony Pictures Television. He serves as executive producer to the critically acclaimed reimagining of One Day At A Time, which was resurrected for a fourth season by PopTV and airing on CBS, Mondays beginning October 5th. He executive produces and co-hosts LIVE In Front of a Studio Audience…, alongside Jimmy Kimmel. The series set record ratings for ABC and won the Emmy for Outstanding Variety Special for two consecutive years. In addition to the soon to be released feature I Carry You With Me, Lear will also be Executive Producing a reimagining of Good Times – animated --coming to Netflix in 2021.
Lear's social and political activism extend beyond the messaging of his programs and he continues to be a strong advocate for civic duty, and progressive American values.
Born in 1922 in New Haven, Connecticut, Lear attended Emerson College before flying 52 combat missions over Europe during World War II. Upon his return, Norman began a successful career writing and producing programs like The Colgate Comedy Hour, and The Martha Raye Show -- ultimately leading to Lear captivating 120 million viewers per week with his iconic shows of the 1970s and '80s — All in the Family, Maude, Good Times, The Jeffersons, Maude, and Mary Hartman, Mary Hartman.
As Lear began witnessing the rise of the radical religious right, he put his television career on hold in 1980 to found People For The American Way. Today, the organization is over one million members and activists strong and continues to fight right-wing extremism while defending constitutional values like free expression, religious liberty, equal justice under the law, and the right to meaningfully participate in our democracy.
Lear is a 2017 Kennedy Center Honoree; a recipient of the National Medal of Arts in 1999, the Peabody Lifetime Achievement Award in 2016; and a proud member of the inaugural group of inductees to the Television Academy Hall of Fame in 1984. He has won six Primetime Emmys and a Golden Globe.
Norman Lear is a father to six, a grandfather to four, and the husband of Lyn Davis Lear.
Dr. Kizzmekia Corbett is a research fellow and the scientific lead for the Coronavirus Vaccines & Immunopathogenesis Team at the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Vaccine Research Center. She received a BS in Biological Sciences, with a secondary major in Sociology, in 2008 from the University of Maryland – Baltimore County, where she was a Meyerhoff Scholar and a NIH undergraduate scholar. She then enrolled at University of North Carolina at Chapel Hill, from where she obtained her PhD in Microbiology and Immunology in 2014. A viral immunologist by training, Dr. Corbett uses her expertise to propel novel vaccine development for pandemic preparedness. Appointed to the VRC in 2014, her work focuses on developing novel coronavirus vaccines, including mRNA-1273, a leading candidate vaccine against the virus that causes COVID-19. In response to the ongoing global COVID-19 pandemic, the vaccine concept incorporated in mRNA-1273 was designed by Dr. Corbett's team from viral sequence and rapidly deployed to industry partner, Moderna, Inc., for FDA-approved Phase 1 clinical trial, which unprecedently began only 66 days from the viral sequence release. Following promising results in animal models and humans, mRNA-1273 is currently in Phase 3 clinical trial. Alongside mRNA-1273, Dr. Corbett's team boasts a portfolio which also includes universal coronavirus vaccine concepts and novel therapeutic antibodies. Additionally, Dr. Corbett spent several years working on a universal influenza vaccine, which is slated for Phase 1 clinical trial. In all, she has fifteen years of expertise studying dengue virus, respiratory syncytial virus, influenza virus, and coronaviruses. Along with her research activities, Dr. Corbett is an active member of the NIH Fellows Committee and avid advocator of STEM education and vaccine awareness in the community. Combining her research goals with her knack for mentoring, Dr. Corbett aims to become an independent principal investigator.
Dr. Tom Frieden is a national and global leader who has spent his career working to improve health in the United States and around the world. Dr. Frieden is one of the world's top experts in prevention of cardiovascular disease, tobacco control, tuberculosis, and health policy and administration. @DrTomFrieden and https://www.linkedin.com/in/tom-frieden/
In his career, Dr. Frieden has served as Director of the Centers for Disease Control and Prevention and Commissioner of the New York City Health Department. His work established New York City's tuberculosis control program and overall health department as models for the world, he created effective programs in India, and improved morale, effectiveness, and impact at the Centers for Disease Control and Prevention. Dr. Tom Frieden's influential publications have explained what actions are needed to improve health, how to implement them and why they work.
Dr. Tom Frieden is now President and CEO of Resolve to Save Lives, a $225 million, five-year initiative to prevent epidemics and cardiovascular disease. Resolve to Save Lives was launched in September of 2017 with support from Bloomberg Philanthropies, the Chan Zuckerberg Initiative, and the Bill and Melinda Gates Foundation and partners countries around the world.
Dr. Tom Frieden is a physician with advanced training in internal medicine, infectious disease, public health, and epidemiology. Over the past 25 years, Dr. Tom Frieden has led and launched numerous initiatives and campaigns, including:
As Director, Dr. Frieden led the Centers for Disease Control and Prevention (CDC) work that ended the Ebola epidemic and launched an initiative that will prevent 500,000 heart attacks and strokes. He sounded the alarm and accelerated progress addressing the epidemic of opioid use, and increased effective action on the front lines to find and fight winnable battles that protect and improve health in the United States and around the world (2009-2017).
As the first Director of International Health Programs of Bloomberg Philanthropies, Dr. Frieden designed and launched the Bloomberg Initiative to Reduce Tobacco Use, a program that has prevented more than 35 million deaths around the world (2006-2009, pro bono).
As Health Commissioner, he led health transformation in New York City, increasing life expectancy by 3 years, preventing more than 100,000 deaths from smoking, and spurring national and global action on, among other areas, better epidemiologic understanding and control of public health problems including HIV, tobacco control, nutrition, as well as the integration of health care and public health. He also reorganized the department to increase financial sustainability and optimize health impact (2002-2009).
Dr. Tom Frieden guided the Indian tuberculosis control program to improve diagnosis and treatment rapidly, creating the largest and most rapidly expanding effective tuberculosis control program in the world that has saved at least 3 million lives (1996-2002).
He led control of the largest outbreak of multidrug-resistant tuberculosis ever to occur in the United States by creating a tuberculosis control program that is a model for the United States and the world. This program emphasized intensive community outreach, clinical excellence, effective integration of health care and public health, ongoing analysis and publication of key epidemiological and program aspects, and rigorous accountability (1990-1996).
Dr. Frieden earned his medical and public health degrees from Columbia University, completed an infectious disease Fellowship at Yale University, and was an Epidemic Intelligence Service Officer at CDC.
Paul Stamets, speaker, author, mycologist, medical researcher and entrepreneur, is considered an intellectual and industry leader in fungi: habitat, medicinal use, and production. He lectures extensively to deepen the understanding and respect for the organisms that literally exist under every footstep taken on this path of life.
Paul is the author of six books (including Mycelium Running: How Mushrooms Can Help Save the World, Growing Gourmet & Medicinal Mushrooms, and Psilocybin Mushrooms of the World), he has discovered and named numerous new species of psilocybin mushrooms. Paul has been awarded more than 40 patents with several patent applications in queue for unexpected beneficial activity of psilocybin analogues stacked with other substances.
He has received numerous awards, including: Invention Ambassador (2014-2015) for the American Association for the Advancement of Science (AAAS), the National Mycologist Award (2014) from the North American Mycological Association (NAMA), and the Gordon & Tina Wasson Award (2015) from the Mycological Society of America (MSA). His work has entered into the mainstream of popular culture. In the new Star Trek: Discovery series on CBS, the Science Officer is portrayed by an Astromycologist.... a Lt. Paul Stamets. Paul's work with mycelium is a central theme of this series.
Christiana Musk is the founder of Flourish*ink, a platform for catalyzing conversations on the future of food and curator of food content for the Near Future Summit.
Previously, Christiana Musk was the Executive Director of Food Choice Taskforce, a focused initiative on sustainable diets and led the food system program for Avatar Alliance Foundation (both founded by filmmaker James Cameron & Suzy Amis Cameron) where she worked to protect the science behind the U.S. Dietary Guidelines. Additionally, Christiana Musk worked alongside think tank Chatham House to develop award-winning research Livestock – Climate Change's Forgotten Sector: Global Public Opinion on Meat and Dairy Consumption. Her food policy research at City University of London, which sustainably addresses the demand for animal sources foods: A Discourse Analysis of Public Speeches Representing Competing World Views, was awarded the British Farmer's Livery WCF Prize for best dissertation to contribute to food and farming in the UK.
Musk was a co-founder of Zaadz.com, an early online social network for people who want to change the world, which was sold to Gaiam, inc. in 2007 and a founding partner of the leading clean energy retail company in the country, Green Mountain Energy, which sold to NRG inc. in 2011. Since 2008, Musk has been an operating partner at Satori Capital and serves on the board of Unreasonable Group, an accelerator for entrepreneurs offering solutions to global challenges. Musk has also been writing about sustainability, clean tech, and food issues for the Huffington Post since 2006, contributes to the World Positive, and Future of Food platforms on Medium and has worked on or advised several documentaries and their social action campaigns, including Leonardo di Caprio's The 11th Hour, as well as Racing Extinction, and Game Changers.
A sought-after public speaker, she has presented to audiences around the world from the United Nations to the Aspen Ideas Festival, the EAT Forum, and Summit Series. Christiana Musk's unique perspective has landed her on the cover of Kiplinger's and inside The New York Times, C Magazine, the Dallas Morning News, and The Herald Tribune, among others.
Christiana lives in Boulder Colorado with food entrepreneur Kimbal Musk, founder of The Kitchen Restaurant Group, urban farm incubator Square Roots, and Big Green—the largest learning garden non-profit in the world. He serves on the boards of SpaceX, and Tesla. They have four delightful children and enjoy cooking and hiking and singing Johnny Cash duets together.
Dr. Iya Khalil is a technology entrepreneur and physicist with a vision of transforming medicine and healthcare into a discipline that is quantitative, predictive, and patient-centric via AI and big data. Recognized by President Obama at a White House dinner as a leading entrepreneur in genomic medicine, she has co-founded two AI and machine learning companies: Gene Network Sciences Inc. and GNS Healthcare. Dr. Khalil is the co-inventor of the proprietary AI and machine learning software platform that underpins both entities. Her machine learning and AI expertise spans 20 years with applications in drug discovery, drug development, clinical trial optimization, real world evidence and pharmaceutical commercial applications, and treatment algorithms that can be applied at the point of care. Dr. Khalil has published and presented extensively in AI and machine learning for healthcare, including peer-reviewed journal articles and poster presentations at scientific conferences such as ASCO, AACR, ASH, ISPOR and EASL.
She was directly responsible for accelerating the launch of the GNS' pharmaceutical and precision medicine business, well before machine learning and AI was recognized by pharma as a key strategic need. She excels at commercializing complex and impactful technologies, having launched several successful collaborations with major pharmaceutical companies including Roche, Sanofi, Gilead, Novartis, Pfizer, Celgene with major foundations and providers including MMRF, CHDI, Dana Farber, and Providence Swedish, as well as between pharmaceutical companies and payers to enable value-based reimbursement models.
In 2018, Dr. Khalil was named one of Inc. magazine's list of top female founders. In 2019, she was among Forbes top women-led startups that are "crushing tech" and was profiled as one of the women making artificial intelligence more accessible and less scary. She also was named to the PharmaVOICE 100 list of the most inspiring people in the life sciences industry for her abilities to build bridges across the life science and healthcare industries, bringing people together to harness the power of computational modeling to change the lives of patients. She is a frequent speaker at industry conferences including Exponential Medicine, Milken Global Conference, Health 2.0, SXSW, Bio, and TEDX.
Dr. Khalil serves as an advisor to the Bill and Melinda Gates Foundation, is on the board of the Accelerated Cure Project, the Scientific Advisory Board of Biocentury Innovations, the Advisory Board of the Convergence Forum, and the Board of Advisors of Life Sciences Cares. Recently, she was appointed to the Massachusetts Center for Health Information and Analysis (CHIA) Oversight Council by Governor Baker.
Iya received her PhD and MS in Physics from Cornell University. In her spare time, she loves to advise early startups, spend time with her family and friends, travel, cook Libyan cuisine, and enjoy the outdoors. She is also fluent in Arabic. She is a passionate member of Springboard enterprises, the largest network of innovators, investors and influencers who are dedicated to building high-growth women led technology companies.
Dr. Strathdee is an infectious disease epidemiologist who is Associate Dean of Global Health Sciences and Harold Simon Professor of Medicine at the University of California San Diego where she codirects the Center for Innovative Phage Applications and Therapeutics (IPATH). Strathdee was recently credited with saving her husband's life from a deadly superbug infection using bacteriophages –viruses that attack bacteria. The case, which involved cooperation from three universities, the U.S. Navy and researchers across the globe, shows how phage therapy is a future weapon against multi-drug resistant bacterial infections which are expected to kill 10 million people per year by 2050. Strathdee and Patterson co-authored a book on their story called The Perfect Predator: A Scientist's Race to Save Her Husband from a Deadly Superbug. For her efforts to revitalize phage therapy in the West, she was named one of TIME magazine's Most Influential People in Health Care in 2018.
LIFE ITSELF is an in-person, retreat style gathering of about 550 people.
The conference begins at 5pm Tuesday Sept 28th and concludes by 12pm Friday Oct 1st, 2021.
The cost to register is $4,000 (full refund policy below).
All registrations are reviewed to curate an audience of thinkers, leaders, inventors and entrepreneurs — from technology, research, entertainment, government and business — colliding to advance human health & happiness. We aim for this to be a meaningful and impactful gathering. If you share our goals, we welcome you to be a part of LIFE ITSELF.
* Full refund available until June 1st, 2021 (minus $150 credit card fee), to alleviate any concerns from the pandemic. Discounted rooms at the iconic Hotel Del Coronado start at $299 (link provided upon registration confirmation). Your credit card will only be charged once your registration is approved, usually within 48 hours. There is limited seating and this event will sell out.
Group code "" not found
Thank you! Your registration has been received and will be reviewed within 48 hours.
If confirmed, you will receive a confirmation by email including a link to book your a room at the iconic Hotel Del, at our group rate.
You will not be charged
until your registration is confirmed.
LIFE ITSELF 2021
September 28th - October 1st, 2021
Add to Calendar
|Total Amount Due|
If you have any questions, please contact email@example.com